Role of neoadjuvant chemotherapy and radiotherapy in locally advanced carcinoma of the cervix

被引:1
|
作者
Katke, Rajshree Dayanand [1 ]
Shivhar, Rewadkar Mahesh [2 ]
Pagare, Priyanka [3 ,4 ]
机构
[1] Cama & Albless Hosp, Grant Govt Med Coll, Dept OBGY, Bombay, Maharashtra, India
[2] Cama & Albless Hosp, Dept Radiotherapy, Bombay, Maharashtra, India
[3] Grant Govt Med Coll, Dept OBGY, Bombay, Maharashtra, India
[4] Sir JJ Grp Hosp, Bombay 400001, Maharashtra, India
来源
关键词
Carcinoma cervix; chemotherapy; neoadjuvant chemotherapy; radiotherapy;
D O I
10.4103/2278-0513.197888
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To study the outcome and complications of neoadjuvent chemotherapy in locally advanced Carcinoma of Cervix in Indian patients. To study the outcome and complications of Radiotherapy in locally advanced Carcinoma of Cervix in Indian patients. Materials and Methods: It is a Prospective analytical study of 95 (n=95) patients registered in the Out-patient section (OPD) of Department of Radiation Therapy and Oncology and indoor patients in gynaec oncology ward in tertiary care institute with histopathologically proven carcinoma of cervix were included in the study. Study duration was from August 2012 to August 2014. Patients with Histologically confirmed cases of carcinoma of cervix with FIGO stage IIB to IVA who were suitable for chemoradiotherapy were included in the study. The baseline characteristics Age, Parity, Weight, Height, Body Surface Area, Socioeconomic Status, FIGO Staging, Histological Variety of Carcinoma Cervix, pre and post treatment ECOG score were noted. The median follow up period was 18 months. All patients were given 3 cycles of Neoadjuvent chemotherapy with each cycle 3 weeks apart, consisting of the drugs dose calculated according to body surface area, Injection Paclitaxel was given as intravenous infusion in a dose of 175 mg /m(2) on day 1 of chemotherapy cycle whereas Injection Cisplatin was given in a dose of 60 mg /m(2) intravenous infusion in two divided doses on day 1 and day 2 of neoadjuvent chemotherapy cycle. NACT was followed by concurrent chemoradiotherapy which included conventional fractionated radiotherapy (CFR) with weekly injection cisplatin 35mg/m(2), EBRT of total dose 50Gy (Gray) in 25 fractions, 200cGy (centigray) per fraction daily for 5 days a week and brachytherapy i.e. Intracavitary Radiation Therapy (ICRT) was given. Results: RECIST 1.0 criterion was used for assessment of the response to treatment. Out of 95 patients, 72 patients (75.78%) had complete response. Partial response was seen in 13 patients (13.68%). Stable disease was seen in 7 patients (7.3)%. 3 patients (3.15%) had progressive disease. Subjective response was evaluated after asking the patient about status of their presenting symptoms one month after completion of whole treatment. Out of 90 patients who had vaginal discharge, 80 patients (88.89%) got relief after complete treatment. Out of 65 patients who had vaginal bleeding, 59 patients (90.76%) were free of this symptom at the completion of treatment. Out of 36 patients who suffered with pelvic discomfort at the start of therapy, 16 patients (44.44%) got symptomatic improvement. During the course of treatment, 56 patients (58.94%) developed Nausea and Vomiting, 30 patients (31.57%) had diarrhoea, 10 patients (10.52%) had cystitis, 7 patients (7.36%) had proctitis, 9 patients (9.47%) developed peripheral neuropathy, 15 patients (15.78%) suffered fever and rash. Renal complications occurred in 7 patients (7.36%). Hematological side effects including anemia neutropenia and thrombocytopenia were noted in 25 patients (26.31%) Median follow-up period for patients was 18 months. Overall survival rate at 1 year after treatment was 74.73% whereas Disease free survival rate at 1 year after treatment was 69.47%. Conclusions: We conclude that, the study has demonstrated a good response rate to NACT followed by CRT in patients with locally advanced carcinoma of cervix with regard to tumour response, overall and disease free survival. The combination of paclitaxel with cisplatin for use in neoadjuvnant chemotherapy showed acceptable adverse effects.
引用
收藏
页码:365 / 368
页数:4
相关论文
共 50 条
  • [41] Neoadjuvant chemotherapy to radiation and concurrent chemoradiation for locally advanced squamous cell carcinoma of the cervix: A review of the recent literature
    Colombo, A
    Landoni, F
    Maneo, A
    Zanetta, G
    Nava, S
    Tancini, G
    TUMORI JOURNAL, 1998, 84 (02): : 229 - 237
  • [42] The role of radiotherapy in locally advanced pancreatic carcinoma
    Ruchika Gutt
    Stanley L. Liauw
    Ralph R. Weichselbaum
    Nature Reviews Gastroenterology & Hepatology, 2010, 7 : 437 - 447
  • [43] The role of radiotherapy in locally advanced pancreatic carcinoma
    Gutt, Ruchika
    Liauw, Stanley L.
    Weichselbaum, Ralph R.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2010, 7 (08) : 437 - 447
  • [44] Postmastectomy Radiotherapy for Locally Advanced Breast Cancer Receiving Neoadjuvant Chemotherapy
    Meattini, Icro
    Cecchini, Sara
    Di Cataldo, Vanessa
    Saieva, Calogero
    Francolini, Giulio
    Scotti, Vieri
    Bonomo, Pierluigi
    Mangoni, Monica
    Greto, Daniela
    Nori, Jacopo
    Orzalesi, Lorenzo
    Casella, Donato
    Simoncini, Roberta
    Fambrini, Massimiliano
    Bianchi, Simonetta
    Livi, Lorenzo
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [45] The role of neoadjuvant chemotherapy in advanced ovarian carcinoma
    Vergote, IB
    De Wever, I
    Tjalma, W
    Van Gramberen, M
    Van Dam, P
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S305 - S305
  • [46] Neoadjuvant chemotherapy followed by surgery in locally advanced cervical carcinoma
    Duenas-Gonzalez, A
    Lopez-Graniel, CM
    Mota, A
    Mohar, A
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (12) : 2908 - 2909
  • [47] Concurrent image-guided intensity modulated radiotherapy and chemotherapy following neoadjuvant chemotherapy for locally advanced nasopharyngeal carcinoma
    Shueng, Pei-Wei
    Shen, Bing-Jie
    Wu, Le-Jung
    Liao, Li-Jen
    Hsiao, Chi-Huang
    Lin, Yu-Chin
    Cheng, Po-Wen
    Lo, Wu-Chia
    Jen, Yee-Min
    Hsieh, Chen-Hsi
    RADIATION ONCOLOGY, 2011, 6
  • [48] Radiotherapy for patients with locally advanced esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy combined with chemotherapy
    Kong, Yue
    Su, Miaoyi
    Fang, Jun
    Chen, Mengyuan
    Zheng, Chao
    Jiang, Youhua
    Tao, Kaiyi
    Wang, Changchun
    Qiu, Guoqin
    Ji, Yongling
    Wang, Yuezhen
    Yang, Yang
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [49] Concurrent image-guided intensity modulated radiotherapy and chemotherapy following neoadjuvant chemotherapy for locally advanced nasopharyngeal carcinoma
    Pei-Wei Shueng
    Bing-Jie Shen
    Le-Jung Wu
    Li-Jen Liao
    Chi-Huang Hsiao
    Yu-Chin Lin
    Po-Wen Cheng
    Wu-Chia Lo
    Yee-Min Jen
    Chen-Hsi Hsieh
    Radiation Oncology, 6
  • [50] PREOPERATIVE CHEMOTHERAPY (NEOADJUVANT) IN LOCALLY ADVANCED GASTRIC-CARCINOMA
    ROUGIER, P
    LASSER, P
    ELIAS, D
    PATHOLOGIE BIOLOGIE, 1993, 41 (01): : 75 - 75